Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
clinical trial phase
|
| gptkbp:duration |
several months
|
| gptkbp:focusesOn |
safety
dosage |
| gptkbp:goal |
determine safe dosage range
identify side effects |
| https://www.w3.org/2000/01/rdf-schema#label |
Phase I
|
| gptkbp:involves |
small number of participants
|
| gptkbp:participantsAre |
healthy volunteers
|
| gptkbp:precededBy |
Phase II
|
| gptkbp:successLeadsTo |
Phase II
|
| gptkbp:usedIn |
vaccine development
drug development |
| gptkbp:bfsParent |
gptkb:gene_therapy
gptkb:Small_Business_Innovation_Research_(SBIR)_Program gptkb:Small_Business_Technology_Transfer_(STTR)_Program gptkb:Technopark gptkb:Electronic_City gptkb:Electronic_City,_Bangalore gptkb:International_HapMap_Project |
| gptkbp:bfsLayer |
5
|